Heartflow (NASDAQ:HTFL) CEO John C.M. Farquhar Sells 27,230 Shares of Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 27,230 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $50.00, for a total transaction of $1,361,500.00. Following the sale, the chief executive officer owned 360,814 shares in the company, valued at approximately $18,040,700. This trade represents a 7.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Tuesday, August 18th, John C.M. Farquhar sold 32,676 shares of Heartflow stock. The stock was sold at an average price of $45.00, for a total value of $1,470,420.00.
• On Friday, August 14th, John C.M. Farquhar sold 15,560 shares of Heartflow stock. The shares were sold at an average price of $39.06, for a total value of $607,773.60.
• On Monday, August 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.31, for a total value of $638,730.22.
• On Friday, July 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $27.75, for a total value of $626,095.50.
• On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The shares were sold at an average price of $35.00, for a total value of $1,361,500.00.
• On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $28.50, for a total value of $643,017.00.

Heartflow Stock Performance

HTFL stock opened at $49.89 on Wednesday. The company’s 50 day moving average price is $31.36 and its 200 day moving average price is $28.63. The firm has a market capitalization of $4.34 billion and a price-to-earnings ratio of -27.26. Heartflow, Inc. has a fifty-two week low of $20.13 and a fifty-two week high of $51.19.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The company had revenue of $64.08 million during the quarter. The company’s quarterly revenue was up 47.7% compared to the same quarter last year. Equities analysts forecast that Heartflow, Inc. will post -0.82 EPS for the current fiscal year.

Hedge Funds Weigh In On Heartflow

Several large investors have recently bought and sold shares of HTFL. California State Teachers Retirement System grew its holdings in shares of Heartflow by 4,293.5% during the second quarter. California State Teachers Retirement System now owns 1,290,403 shares of the company’s stock worth $37,860,000 after purchasing an additional 1,261,032 shares during the last quarter. Mayport LLC boosted its position in shares of Heartflow by 20.0% in the 2nd quarter. Mayport LLC now owns 12,000 shares of the company’s stock valued at $352,000 after purchasing an additional 2,000 shares during the period. Alyeska Investment Group L.P. boosted its position in shares of Heartflow by 55.6% in the 2nd quarter. Alyeska Investment Group L.P. now owns 350,000 shares of the company’s stock valued at $10,269,000 after purchasing an additional 125,000 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Heartflow by 3.6% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,465,650 shares of the company’s stock worth $43,002,000 after buying an additional 50,822 shares during the last quarter. Finally, XXEC Inc. acquired a new position in Heartflow during the second quarter worth approximately $18,364,000.

Analyst Ratings Changes

HTFL has been the subject of a number of recent analyst reports. Robert W. Baird set a $45.00 price target on Heartflow in a report on Friday, August 14th. William Blair started coverage on Heartflow in a report on Monday, May 4th. They issued an “outperform” rating on the stock. Benchmark reissued a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. Weiss Ratings upgraded Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 7th. Finally, Wells Fargo & Company increased their price target on shares of Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $43.43.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.